Senate Strips Pay-For-Delay Ban From Spending Bill
The U.S. Senate has abandoned an amendment sent to it by the House of Representatives that would have limited pharmaceutical companies' ability to enter into legal agreements to delay the market...To view the full article, register now.
Already a subscriber? Click here to view full article